Shin-Ichiro Nishimura Selected Research

Shin-Ichiro Nishimura Research Topics

Disease

43	Neoplasms (Cancer) 04/2022 - 01/2004
7	Neoplasm Metastasis (Metastasis) 04/2020 - 06/2002
7	Carcinoma (Carcinomatosis) 01/2020 - 07/2008
6	Prostatic Neoplasms (Prostate Cancer) 11/2019 - 01/2008
6	Hepatocellular Carcinoma (Hepatoma) 09/2015 - 05/2007
4	Carcinogenesis 04/2022 - 01/2008
4	Breast Neoplasms (Breast Cancer) 03/2020 - 02/2016
4	Human Influenza (Influenza) 12/2019 - 06/2010
4	Pancreatic Neoplasms (Pancreatic Cancer) 05/2015 - 07/2007
4	Inflammation (Inflammations) 03/2015 - 02/2011
4	Infections 06/2013 - 09/2007
3	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 09/2007
3	Disease Progression 11/2019 - 09/2002
3	Communicable Diseases (Infectious Diseases) 06/2013 - 11/2006
3	Type 2 Diabetes Mellitus (MODY) 08/2010 - 10/2007
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 11/2019 - 11/2014
2	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2016 - 09/2015
2	Central Nervous System Diseases (CNS Diseases) 08/2016 - 09/2015
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2016 - 08/2015
1	Adenoma (Adenomas) 04/2022
1	Liver Neoplasms (Liver Cancer) 12/2020
1	Adenocarcinoma 04/2020
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 08/2016
1	Weight Gain 04/2016
1	Adenocarcinoma of Lung 02/2016
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2016
1	Neovascular Glaucoma 01/2016
1	Autoimmune Pancreatitis 01/2016
1	Liver Diseases (Liver Disease) 09/2015
1	Chronic Hepatitis (Chronic Active Hepatitis) 09/2015
1	Huntington Disease (Huntington's Disease) 09/2015
1	Cysts 07/2015
1	Pancreatic Intraductal Neoplasms 07/2015
1	Fibrosis (Cirrhosis) 03/2015
1	Alcoholic Fatty Liver 03/2015

Drug/Important Bio-Agent (IBA)

44	Polysaccharides (Glycans)IBA 04/2022 - 01/2007
20	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2007
10	Glycoproteins (Glycoprotein)IBA 08/2018 - 06/2007
9	Proteins (Proteins, Gene)FDA Link 04/2020 - 06/2002
6	GlycopeptidesIBA 01/2020 - 01/2013
6	Monoclonal AntibodiesIBA 10/2015 - 04/2006
5	AntibodiesIBA 11/2020 - 12/2017
5	CarbohydratesIBA 04/2020 - 01/2004
5	EpitopesIBA 01/2020 - 01/2008
4	Peptides (Polypeptides)IBA 04/2020 - 01/2008
4	MucinsIBA 04/2020 - 02/2011
4	Tn antigenIBA 03/2020 - 12/2014
4	OligosaccharidesIBA 02/2013 - 04/2006
3	Immunoglobulin G (IgG)IBA 03/2020 - 06/2007
3	AndrogensIBA 11/2019 - 04/2012
3	AcetylglucosamineIBA 10/2019 - 10/2007
3	Pharmaceutical PreparationsIBA 08/2016 - 08/2010
3	N-Acetylneuraminic Acid (Sialic Acid)IBA 11/2012 - 09/2005
2	Mannose (D-Mannose)IBA 01/2022 - 11/2011
2	VaccinesIBA 03/2020 - 10/2015
2	AntigensIBA 01/2020 - 12/2017
2	Mucin-1 (CA 15-3 Antigen)IBA 01/2020 - 11/2017
2	AutoantibodiesIBA 01/2020 - 01/2020
2	Uridine Diphosphate (UDP)IBA 10/2019 - 02/2011
2	GlycosphingolipidsIBA 01/2018 - 01/2011
2	Epidermal Growth Factor (EGF)IBA 01/2017 - 02/2016
2	LigandsIBA 01/2017 - 02/2016
2	alanylprolineIBA 01/2016 - 01/2013
2	arginylprolineIBA 01/2016 - 01/2013
2	Galactose (Galactopyranose)FDA LinkGeneric 12/2014 - 06/2007
2	LectinsIBA 12/2014 - 01/2004
2	FucoseIBA 10/2013 - 06/2007
2	Biological ProductsIBA 01/2013 - 12/2010
2	Galectins (Galectin)IBA 11/2012 - 01/2004
2	Cyclin-Dependent Kinase Inhibitor p16IBA 11/2012 - 07/2007
2	EnzymesIBA 11/2012 - 09/2007
2	ParaffinIBA 12/2010 - 04/2006
2	Indicators and Reagents (Reagents)IBA 06/2010 - 11/2008
2	GangliosidesIBA 01/2009 - 09/2005
2	Cholera ToxinIBA 09/2007 - 09/2005
2	Therapeutic UsesIBA 05/2007 - 04/2004
2	SolutionsIBA 04/2004 - 01/2004
1	Plasminogen Activators (Plasminogen Activator)IBA 12/2020
1	Threonine (L-Threonine)FDA Link 01/2020
1	Glycoside Hydrolases (Endoglycosidases)IBA 10/2019
1	GalactosidasesIBA 10/2019
1	Hexosaminidases (Hexosaminidase)IBA 10/2019
1	Immunoglobulins (Immunoglobulin)IBA 12/2017
1	Notch1 ReceptorIBA 01/2017
1	Phosphorylcholine (Phosphocholine)IBA 09/2015
1	Arginine (L-Arginine)FDA Link 09/2015
1	KetonesIBA 09/2015
1	His-His-His-His-His-His ((His)6)IBA 09/2015
1	gamma-Aminobutyric Acid (GABA)IBA 09/2015
1	thiamine triphosphorate (TTP)IBA 05/2015
1	Gemcitabine FDA Link 05/2015
1	Thomsen-Friedenreich antigenIBA 12/2014

Therapy/Procedure

9	Therapeutics 01/2020 - 06/2002
4	Drug Therapy (Chemotherapy) 08/2010 - 06/2002
2	Lasers (Laser) 12/2020 - 03/2014
2	Castration 11/2019 - 11/2014
1	Quantum Dots (Quantum Dot) 01/2022
1	Radiotherapy 01/2018
1	Ligation 09/2015